Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Repaglinide (1mg)
Therapeutic Category
Antidiabetic, Cardiology, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Repacept Tablet contains Repaglinide (1mg), an oral antidiabetic medication that helps regulate postprandial blood glucose levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release insulin, thereby lowering blood sugar after meals.
Repaglinide belongs to the meglitinide class of drugs, known for their rapid action and short duration, making them particularly effective for controlling meal-related glucose spikes. This property allows for flexible dosing and minimizes the risk of hypoglycemia compared to other agents.
Repacept Tablet is part of the antidiabetic and endocrinology segment, widely recommended for improving glycemic control in adults with type 2 diabetes, especially when diet and exercise alone are insufficient.
For pharmaceutical distributors and franchise owners, Repacept Tablet offers an excellent PCD pharma franchise and third-party manufacturing opportunity in the growing diabetic care market. Its strong clinical efficacy and consistent demand ensure long-term business growth and sustainability across India.
Common side effects include mild hypoglycemia, headache, dizziness, and gastrointestinal discomfort. Rarely, allergic reactions, visual disturbances, or liver enzyme changes may occur. Consult your doctor if any side effects persist or worsen.
Repacept Tablet is indicated for the treatment of type 2 diabetes mellitus in adults, particularly when blood glucose levels are not adequately controlled by diet and exercise alone. It is especially useful for patients who experience elevated blood sugar levels after meals.
Take Repacept Tablet before meals as prescribed by your physician. Skip the dose if you skip a meal to prevent hypoglycemia. Maintain regular blood glucose monitoring and follow a healthy lifestyle plan. Inform your doctor if you have liver disease or are taking other antidiabetic medications.
Store Repacept Tablet in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Carvedilol 12.5 tablet
Composition : Carvedilol CR 10mg Tablet
Composition : Carvedilol CR 20mg Tablet
Composition : Clopidogrel 150 mg Tablet
Composition : Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Clopidogrel 75 mg Tablet
Composition : Clopidogrel 75mg + Aspirin 150mg Tablet
Composition : Astaxanthin (16mg) + Reduced Coenzyme Q10 (200mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Repaglinide I.P. 1mg Tablet has strong demand in the anti-diabetic and metabolic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetes management portfolios.
Medical distributors and agencies can benefit from consistent demand for management of Type 2 Diabetes Mellitus and postprandial (post-meal) blood sugar control. Repaglinide 1mg is a rapid-acting insulin secretagogue that helps control post-meal glucose spikes Commonly used in oral anti-diabetic therapy under physician supervision This strengthens a reliable diabetes-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Repaglinide I.P. 1mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong physician prescriptions, post-meal glucose control demand, steady diabetic patient base, long-term recurring sales, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.